4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-004771
Options or other derivatives
- Chief Executive Officer acquired 165,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Seehra Jasbir · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-21 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +165,000 | 165,000 | D |
Loading xslF345X03/doc4.xml…